Research Articles Library
Literature Analysis Tools
Advanced Search
Filter by PMID, year, source, DOI and other criteria
Literature Analysis
Analyze research trends and hotspots
Batch Export
Export search results to Excel/PDF
Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's disease
Publication Year: 2024 Source: Immunotherapy PMID: 38629330 DOI: 10.2217/imt-2023-0219
Risankizumab is a humanized monoclonal antibody that inhibits the p19 subunit of IL-23 cytokine. Recently it has been approved for the treatment of patients with moderate-to-severe Crohn's disease (CD). We conducted a scoping review to summarize the available data on risankizumab and to define its positioning in the treatment algorithm …
Factors promoting and hindering resilience in youth with inflammatory bowel disease: A descriptive qualitative study
Publication Year: 2024 Source: Nurs Open PMID: 38629398 DOI: 10.1002/nop2.2150
AIM: To explore factors promoting and hindering resilience in youth with inflammatory bowel disease (IBD) based on Kumpfer's resilience framework. DESIGN: A descriptive qualitative study design with an interpretative approach was used. METHODS: Participants consisted of 10 youths with IBD from a tertiary hospital in Beijing (China) recruited using the …
Psychological well-being of children and adolescents with inflammatory bowel disease
Publication Year: 2024 Source: J Pediatr Gastroenterol Nutr PMID: 38629478
No Abstract
Protective effect of soluble dietary fiber from Rosa roxburghii Tratt residue on dextran sulfate sodium-induced ulcerative colitis by regulating serum metabolism and NF-κB pathway in mice
Publication Year: 2024 Source: J Sci Food Agric PMID: 38629513
No Abstract
Factors associated with surgical resection in patients with Crohn's disease: long-term evaluation
Publication Year: 2024 Source: Acta Cir Bras PMID: 38629651
No Abstract
Dietary fiber guar gum-induced shift in gut microbiota metabolism and intestinal immune activity enhances susceptibility to colonic inflammation
Publication Year: 2024 Source: Gut Microbes PMID: 38630030 DOI: 10.1080/19490976.2024.2341457
With an increasing interest in dietary fibers (DFs) to promote intestinal health and the growth of beneficial gut bacteria, there is a continued rise in the incorporation of refined DFs in processed foods. It is still unclear how refined fibers, such as guar gum, affect the gut microbiota activity and …
Clearance of Gut Mucosal SARS-CoV-2 Antigens and Postacute COVID-19 After 2 Years in Patients With Inflammatory Bowel Disease
Publication Year: 2024 Source: Gastroenterology PMID: 38631418
No Abstract
Risk of Cesarean Delivery Among People With Inflammatory Bowel Disease According to Disease Characteristics: A Population-Based Study
Publication Year: 2024 Source: J Obstet Gynaecol Can PMID: 38631434 DOI: 10.1016/j.jogc.2024.102463
OBJECTIVES: It is unclear if use of cesarean delivery in people with inflammatory bowel disease (IBD) is guideline-concordant. We compared the odds of cesarean delivery among primiparous individuals with IBD versus without, overall, and by disease characteristics, as well as time to subsequent delivery. METHODS: Retrospective matched population-based cohort study …
Quality of reporting inflammatory bowel disease randomised controlled trials: a systematic review
Publication Year: 2024 Source: BMJ Open Gastroenterol PMID: 38631808 DOI: 10.1136/bmjgast-2023-001337
OBJECTIVE: Our objective was to perform a systemic evaluation of the risk of bias in randomised controlled trial (RCT) reports published on inflammatory bowel disease (IBD). DESIGN: We assessed the risk of bias using the Cochrane tool, as indicators of poor methodology or subsequently poor reporting. We systematically selected, with …
Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine
Publication Year: 2024 Source: BMJ Open PMID: 38631839 DOI: 10.1136/bmjopen-2023-073639
INTRODUCTION: Characterised by chronic inflammation of the gastrointestinal tract, inflammatory bowel disease (IBD) symptoms including diarrhoea, abdominal pain and fatigue can significantly impact patient's quality of life. Therapeutic developments in the last 20 years have revolutionised treatment. However, clinical trials and real-world data show primary non-response rates up to 40%. …
Need more literature?
The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.
External Resources: Access comprehensive literature databases worldwide